V. Vero

511 total citations
12 papers, 343 citations indexed

About

V. Vero is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, V. Vero has authored 12 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Surgery and 3 papers in Hepatology. Recurrent topics in V. Vero's work include Liver Disease Diagnosis and Treatment (6 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Diet, Metabolism, and Disease (2 papers). V. Vero is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Diet, Metabolism, and Disease (2 papers). V. Vero collaborates with scholars based in Italy, Chile and Canada. V. Vero's co-authors include Antonio Gasbarrini, Luca Miele, Antonio Grieco, Consuelo Cefalo, Fabio Maria Vecchio, Giuseppe La Torre, Maurizio Pompili, M.L. Gabrieli, A. Forgione and Clara De Simone and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Hepatology and Translational research.

In The Last Decade

V. Vero

12 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Vero Italy 8 196 121 75 72 61 12 343
Érika Rabelo Forte de Siqueira Brazil 8 235 1.2× 37 0.3× 81 1.1× 144 2.0× 59 1.0× 12 357
Nick Wlazlo Netherlands 8 155 0.8× 68 0.6× 42 0.6× 55 0.8× 32 0.5× 14 363
De Kai QIU China 11 371 1.9× 118 1.0× 55 0.7× 216 3.0× 24 0.4× 14 548
Ella A.M. van der Voort Netherlands 5 113 0.6× 277 2.3× 19 0.3× 38 0.5× 92 1.5× 5 388
Tetsuharu Oriishi Japan 10 155 0.8× 45 0.4× 56 0.7× 98 1.4× 10 0.2× 21 357
Toru Setsu Japan 11 129 0.7× 95 0.8× 27 0.4× 108 1.5× 12 0.2× 35 315
Alejandra Camino Argentina 4 216 1.1× 21 0.2× 59 0.8× 103 1.4× 29 0.5× 5 324
Evangelia Katsiki Greece 12 305 1.6× 29 0.2× 176 2.3× 98 1.4× 42 0.7× 21 449
C Smyth Ireland 9 61 0.3× 62 0.5× 78 1.0× 23 0.3× 21 0.3× 21 377
Woo-Kyu Jeon South Korea 7 155 0.8× 52 0.4× 86 1.1× 58 0.8× 14 0.2× 14 365

Countries citing papers authored by V. Vero

Since Specialization
Citations

This map shows the geographic impact of V. Vero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Vero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Vero more than expected).

Fields of papers citing papers by V. Vero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Vero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Vero. The network helps show where V. Vero may publish in the future.

Co-authorship network of co-authors of V. Vero

This figure shows the co-authorship network connecting the top 25 collaborators of V. Vero. A scholar is included among the top collaborators of V. Vero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Vero. V. Vero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vitale, Giovanni, Amalia Conti, Sonia Berardi, et al.. (2023). Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis. International Journal of Molecular Sciences. 24(6). 5823–5823. 10 indexed citations
2.
Miele, Luca, Giovanni Cammarota, V. Vero, et al.. (2012). Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. Digestive and Liver Disease. 44(12). 1032–1036. 16 indexed citations
3.
Vero, V., Marco Senzolo, L. Pasulo, et al.. (2011). 578 IS THE PRIMARY IMMUNOSUPPRESSIVE DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE?. Journal of Hepatology. 54. S235–S235. 4 indexed citations
4.
Vero, V. & Antonio Gasbarrini. (2011). The EFSA health claims ‘learning experience’. International Journal of Food Sciences and Nutrition. 63(sup1). 14–16. 14 indexed citations
6.
Miele, Luca, Consuelo Cefalo, Giuseppe La Torre, et al.. (2009). Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. Journal of Hepatology. 51(4). 778–786. 161 indexed citations
7.
Vero, V., et al.. (2009). [The treatment of hepatocellular carcinoma: an update].. PubMed. 100(3). 173–93. 2 indexed citations
8.
Miele, Luca, Francesco Pierconti, Alessandra Forgione, et al.. (2007). Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. European Journal of Gastroenterology & Hepatology. 19(11). 1026–1030. 8 indexed citations
9.
Miele, Luca, Stefania Boccia, C. Cefalo, et al.. (2007). [736] GENETIC AND ENVIRONMENTAL FACTORS RESPONSIBLE FOR OXIDATIVE STRESS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD). Journal of Hepatology. 46. S277–S277. 1 indexed citations
10.
Miele, Luca, M.L. Gabrieli, Alessandra Forgione, et al.. (2006). [Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?].. PubMed. 97(1). 1–5. 5 indexed citations
11.
Grieco, Antonio, A. Forgione, Luca Miele, et al.. (2006). Fatty liver and drugs.. PubMed. 9(5). 261–3. 49 indexed citations
12.
Capristo, Esmeralda, Luca Miele, A. Forgione, et al.. (2006). Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).. PubMed. 9(5). 265–8. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026